Trích dẫn APA

Bai, L., Zhang, P., Zhou, K., Liao, W., & Li, Q. (2019). Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer. Cancer Manag Res.

Trích dẫn kiểu Chicago

Bai, Liangliang, Pengfei Zhang, Kexun Zhou, Weiting Liao, và Qiu Li. "Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer." Cancer Manag Res 2019.

Trích dẫn MLA

Bai, Liangliang, et al. "Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) Versus FOLFOX-4 in Patients With RAS Wild-Type Metastatic Colorectal Cancer." Cancer Manag Res 2019.

Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.